Adam Fein

Specialty drugs shake up field of Rx players

Specialty drugs shake up field of Rx players

The rapid growth of the specialty pharmacy sector, fueled by high-priced specialty drugs, remains one of the leading story lines in the pharmacy industry. Compared with the retail pharmacy arena, the field of players in the specialty Rx market has yet to shake out. But pharmaceutical supply chain and economics expert Adam Fein, CEO of

Rx battle heats up between CVS, Walgreens

Rx battle heats up between CVS, Walgreens

CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS

Walmart, McKesson team up for generic drug sourcing

Walmart, McKesson team up for generic drug sourcing

BENTONVILLE, Ark. — Walmart has become the latest retailer to ally with a pharmaceutical distributor for generic drug sourcing. The mass merchandiser’s partnership with McKesson Corp. includes an expanded long-term distribution pact and will add scale and value for both companies, they said. The agreement positions Walmart and McKesson to compete with partnerships between Walgreens

McKesson-Walmart deal creates ‘intriguing alignment,’ expert says

McKesson-Walmart deal creates ‘intriguing alignment,’ expert says

The expanded distribution agreement between McKesson and Walmart not only brings McKesson a generic drug customer it had been pursuing, but it also “finalizes an intriguing industry channel alignment,” according to pharmacy supply chain expert Adam Fein, president of Pembroke Consulting. In a posting Tuesday on his Drug Channels blog, Fein noted that Walmart was

Outlook: Transition time for drug chains

Outlook: Transition time for drug chains

NEW YORK — Going forward, chain drug stores can bank on the same underlying trends that have fueled the retail pharmacy business in recent years. But the industry as they’ve known it won’t look quite the same. Retailer consolidation, changes in drug purchasing and the influx of specialty drugs are reshaping the competitive arena, industry

Walgreens, OptumRx build ‘new pharmacy solution’

Walgreens, OptumRx build ‘new pharmacy solution’

DEERFIELD, Ill. — Walgreens is partnering with OptumRx to create a new pharmacy benefit to meet consumers’ changing prescription drug needs and help employers, health plans and their members achieve better health outcomes and greater cost savings. OptumRx is UnitedHealth Group’s freestanding pharmacy care services business, managing more than a billion prescriptions annually. Through a

The growing reach of Walgreens Boots Alliance

The growing reach of Walgreens Boots Alliance

The presence of Walgreens Boots Alliance (WBA) across the pharmacy care sector continues to broaden and deepen. Over two days earlier this month, WBA unveiled an integrated pharmacy offering with PBM OptumRx and then announced that it’s boosting its equity stake in drug distributor AmerisourceBergen. The highlight of the offering with OptumRx is that members

Specialty to become bigger Rx sales booster

Specialty to become bigger Rx sales booster

Pharmaceutical supply chain and economics expert Adam Fein, CEO of the Drug Channels Institute, says specialty drugs continue to hoist pharmacy industry sales, according to his firm’s latest analysis. “We project that the pharmacy industry’s revenues will exceed $483 billion in 2020,” stated Fein, author of the 2016 Economic Report on Retail, Mail, and Specialty Pharmacies

WBA shakes up industry with Rite Aid acquisition

WBA shakes up industry with Rite Aid acquisition

DEERFIELD, Ill. — The consolidation of chain drug retailing climaxed last month with Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. In the largest outright purchase of a chain in the industry’s history, WBA agreed to acquire Rite Aid for $9 per share, or $17.2 billion, including debt. The price represents a premium

WBA-Rite Aid deal likely to draw scrutiny from regulators

DEERFIELD, Ill. — Walgreens Boots Alliance may have to divest up to 400 of the Rite Aid stores it is acquiring to satisfy antitrust regulations, analysts said. WBA is not publicly speculating on how many units it will have to shutter, said chief executive officer Stefano Pessina. “We have analyzed things very carefully,” he said

After PBMs weigh in, Valeant drops Philidor

NEW YORK — After CVS Caremark and two other pharmacy benefit managers announced that they are terminating mail-order pharmacy Philidor Rx Services LLC from their networks, Valeant Pharmaceuticals Inc. said it would also sever ties with Philidor. Philidor has been accused of bolstering sales of products made by the Canadian-based drug ­manufacturer Valeant. Joining CVS

CVS to gain more clout by acquiring Target Rx business

CVS to gain more clout by acquiring Target Rx business

WOONSOCKET, R.I. — Continuing its aggressive growth and diversification, CVS Health has purchased Target Corp.’s pharmacy and clinic businesses for some $1.9 billion. The acquisition propels CVS past Walgreens as the nation’s No. 1 pharmacy operator by market share and store count. CVS will have close to 9,500 prescription counters. Walgreens had 8,232 as of

PBM addition key for Rite Aid

PBM addition key for Rite Aid

Rite Aid’s acquisition of PBM EnvisionRx was seen by industry observers as a big plus for the drug chain. Fitch Ratings called the deal “a positive move as it will enable the company to expand its distribution channels by getting a foothold in the specialty and mail-order channels.” “The acquisition is supported by Rite Aid’s improved